Predicting steady‐state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?-Reference-Cited by-同舟云学术

Predicting steady‐state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?

Published:2020-08-19 Issue:5 Volume:8 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol. Res. Perspect.

Author:

Gusella Milena¹^ORCID,Pasini Felice²,Corso Barbara³^ORCID,Bertolaso Laura¹,De Rosa Giovanni⁴,Falci Cristina⁵,Modena Yasmina¹,Barile Carmen¹,Da Corte Z Donatella⁶,Fraccon AnnaPaola²,Toso Silvia⁷,Cretella Elisabetta⁸,Brunello Antonella⁹,Modonesi Caterina¹⁰,Segati Romana¹¹,Oliani Cristina¹,Minicuci Nadia³,Padrini Roberto⁴,

Affiliation:

1. Oncology Unit AULSS5 Polesana Rovigo Italy

2. Oncology Unit Casa di Cura Pederzoli Peschiera del Garda Italy

3. National Research CouncilNeuroscience Institute Padova Italy

4. Clinical Pharmacology Unit of the Department of Medicine (DIMED) University of Padova Padova Italy

5. Oncology Unit 2 Istituto Oncologico Veneto (IOV)IRCCS Padova Padova Italy

6. Oncology Unit Ospedale di Belluno Belluno Italy

7. Oncology Unit Ospedale di Adria Polesana Italy

8. Oncology Unit Ospedale di Bolzano Bolzano Italy

9. Oncology Unit 1 Istituto Oncologico Veneto (IOV)IRCCS Padova Padova Italy

10. Oncology UnitOspedali Riuniti Padova Sud Padova Italy

11. Oncology Unit Ospedale di Feltre Feltre Italy